459133-68-7

Basic information

• Product Name: 3-IODO-5-BROMO-1H-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
• Synonyms: 3-IODO-5-BROMO-1H-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER;TERT-BUTYL 5-BROMO-3-IODO-1H-INDAZOLE-1-CARBOXYLATE;1-Boc-5-Bromo-3-iodo-1H-indazole;1H-Indazole-1-carboxylic acid, 5-broMo-3-iodo-, 1,1-diMethylethyl ester;5-Bromo-3-iodo-1H-Indazole-1-carboxylic acid 1,1-dimethylethyl ester;1-N-Boc-5-bromo-3-iodo-1H-indazole
• CAS NO: 459133-68-7
• Molecular Formula: C₁₂H₁₂BrIN₂O₂
• Molecular Weight: 423.04
• Product Categories: Indazoles
• Mol File: 459133-68-7.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 444℃
• Flash Point: 222℃
• Appearance: /
• Density: 1.91
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.666
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: -4.22±0.50(Predicted)
• CAS DataBase Reference: 3-IODO-5-BROMO-1H-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 3-IODO-5-BROMO-1H-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER(459133-68-7)
• EPA Substance Registry System: 3-IODO-5-BROMO-1H-INDAZOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER(459133-68-7)

Safety Data

• Hazardous Substances Data: 459133-68-7(Hazardous Substances Data)

Usage

General Description

3-Iodo-5-bromo-1H-indazole-1-carboxylic acid tert-butyl ester is a complex chemical compound. It belongs to the class of organic compounds referred to as indazoles, which are aromatic compounds that contain a benzene ring fused to an azole ring. This particular chemical has iodine and bromine as substituents, contributing to its unique atomic structure. As a carboxylic acid ester, it comprises of an ester functional group (-COO-) linked to a tertiary butyl group. Its complex structure influences its chemical properties, behavior, and potential applications, which can be relevant in various areas, including medicine, material science, and chemical research. Information regarding its potential toxicity, safety precautions, or environmental impact may vary based on its concentration, exposure conditions, and manner of use.

InChI:InChI=1/C12H12BrIN2O2/c1-12(2,3)18-11(17)16-9-5-4-7(13)6-8(9)10(14)15-16/h4-6H,1-3H3

Upstream product

• 53857-57-1 5-bromo-1H-indazole 
• 24424-99-5 di-tert-butyl dicarbonate 
• 459133-66-5 5-bromo-3-iodo-1H-indazole 

Downstream Products

• 1093306-79-6 tert-butyl 5-bromo-3-phenyl-1H-indazole-1-carboxylate 
• 1093306-84-3 tert-butyl 3-phenyl-5-((trimethylsilyl)ethynyl)-1H-indazole-1-carboxylate 
• 459133-81-4 5-bromo-3-[3-(toluene-4-sulfonylamino)-prop-1-ynyl]-indazole-1-carboxylic acid tert-butyl ester 
• 1374351-09-3 C₂₆H₂₃F₂N₇ 

Relevant articles and documents

METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION

Mutations in oncogenes and tumor suppressors contribute to the development and progression of cancer. The present disclosure describes compounds and methods that restore DNA binding affinity of p53 mutants. The compounds of the present disclosure can bind to mutant p53 and restore the ability of the p53 mutant to bind DNA and activate downstream effectors involved in tumor suppression. The disclosed compounds can be used to reduce the progression of cancers that contain a p53 mutation.

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

NOVEL COMPOUNDS THAT ARE ERK INHIBITORS

Disclosed are the ERK inhibitors of formula (1): and the pharmaceutically acceptable salts thereof, wherein: A is a five membered monocyclic heteroaryl ring; and B is a monocyclic heterocycloalkyl ring, or a monocyclic heterocycloalkenyl ring, or a bridge